Digital interventions for psychosis or bipolar disorder: we don’t know very much at all

bogdan-glisik-780672-unsplash

Mark Brown mulls over a new systematic review on factors affecting the implementation of digital health interventions for people with psychosis or bipolar disorder, and their family and friends.

[read the full story...]

A psychological victory for the domestic violence and abuse sector: the PATH trial

Young adults who reported depressive and/or suicidality symptoms in adolescence were significantly more likely to have experienced relationship violence in their romantic relationships

Emma Yapp summarises two new studies out yesterday looking at the PATH intervention (Psychological Advocacy Towards Healing), a CBT-informed psychological intervention delivered by trained domestic violence and abuse (DVA) advocates in specialist services.

[read the full story...]

Do you have my back? Perceived social support, loneliness, and its impact on mental health outcomes

warren-wong-238677-unsplash

In the lead up to our Loneliness Mental Health Question Time on 3rd Dec 2018, Dr Michelle Lim summarises a recent systematic review on the associations between loneliness and perceived social support and outcomes of mental health problems.

[read the full story...]

Preventing psychosis: no one intervention is better than the rest

candice-picard-1111655-unsplash

A group of UCL Mental Health Masters students summarise a recent network meta-analysis that highlights a lack of evidence about specific interventions for preventing psychosis.

[read the full story...]

Physical health inequalities in primary care

list-not-equals

Andy Bell from Centre for Mental Health and the Equally Well UK collaborative, calls for action in response to the Public Health England briefing on severe mental illness and physical health inequalities.

[read the full story...]

Is the incidence of schizophrenia in South-East London really 10 times higher than in Santiago, Spain?

2782048744_3fc0d9280c_b

Vishal Bhavsar reviews an EU study of nearly 3,000 people across 6 EU countries, looking at the treated incidence of schizophrenia and psychotic disorders. It helps us better understand who gets psychosis, when, and where.

[read the full story...]

What can genetics tell us about the link between cannabis and schizophrenia? #MHQT

chase-fade-1055517-unsplash

Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.

[read the full story...]

Loneliness in psychosis and related psychological and social factors

iz-zy-140216-unsplash

Jingyi Wang publishes her debut blog on a recent systematic review of loneliness in psychosis, which shows that the relationship between loneliness and psychosis remains poorly understood due to a lack of high quality studies.

[read the full story...]

Is Cannabidiol (CBD) an effective antipsychotic?

24281909498_a080b71a94_k

Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.

[read the full story...]

Low dose Amisulpride for very late onset schizophrenia-like psychosis: the ATLAS study

kiwihug-393309-unsplash

Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).

[read the full story...]